Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability of a Formulation of Dienogest 2.0 mg Coated Tablets With Regards to the Marketed Reference Product

NCT04230083 is registered in ClinicalTrials.gov with Laboratorios Andromaco S.A. as lead sponsor.

NCT NCT04230083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04230083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability of a Formulation of Dienogest 2.0 mg Coated Tablets With Regards to the Marketed Reference Product
Lead sponsor
Laboratorios Andromaco S.A.
Phase
Phase 1
Overall status
Completed
Start date
December 7, 2019
Completion date
December 24, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence